YOUR NEW PARTNER IN DRUG DISCOVERY

Mirimus is an XPRIZE award-winning biotech and preclinical CRO delivering scalable solutions for the preclinical evaluation of novel therapeutic targets through the use of our advanced genetically engineered in vivo models. With cutting-edge gene editing and RNA interference (RNAi) technologies, we are leaders in developing human models of disease.

PRECLINICAL SERVICES

We are driving advancements in human health by providing high-quality animal and cell models for critical in vivo studies. We empower researchers to gain precise control over in vivo gene expression by designing precise, translatable, genetically-engineered animal and cellular models with potent, reversible gene silencing.

ANIMAL MODELS

Customize RNAi and CRISPR/Cas9 mouse and rat models with potent, reversible gene silencing for drug discovery and target validation.

Learn More

3D CELL MODELS

Recreate the architecture and physiology of human organs with clinically relevant 3D tissue cultures developed from induced pluripotent stem cells (iPSCs).

Learn More

RNAi THERAPEUTICS

Unlock the therapeutic potential of RNA Interference (RNAi) and accelerate the development of new therapies for the world’s most challenging diseases.

Learn More

OUR  PARTNERS

OUR  PARTNERS

CONTACT US

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Black and white Mirimus log

760 Parkside Avenue, Suite 206
Brooklyn, NY 11226
[email protected]
+1 (833) 647-4687